Lorente Leonardo, Henry Christophe, Martín María M, Jiménez Alejandro, Mora María L
Department of Intensive Care, Hospital Universitario de Canarias, La Laguna, Santa Cruz de Tenerife, Spain.
Crit Care. 2005;9(6):R631-5. doi: 10.1186/cc3824. Epub 2005 Sep 28.
Central venous catheterization is commonly used in critically ill patients and may cause different complications, including infection. Although there are many studies about CVC-related infection, very few have analyzed it in detail. The objective of this study was to analyze the incidence of catheter-related local infection (CRLI) and catheter-related bloodstream infection (CRBSI) with central venous catheters (CVCs) according to different access sites.
This is a prospective and observational study, conducted in a 24-bed medical surgical intensive care unit of a 650-bed university hospital. All consecutive patients admitted to the ICU during 3 years (1 May 2000 and 30 April 2003) were included.
The study included 2,018 patients. The number of CVCs and days of catheterization duration were: global, 2,595 and 18,999; subclavian, 917 and 8,239; jugular, 1,390 and 8,361; femoral, 288 and 2,399. CRLI incidence density was statistically higher for femoral than for jugular (15.83 versus 7.65, p < 0.001) and subclavian (15.83 versus 1.57, p < 0.001) accesses, and higher for jugular than for subclavian access (7.65 versus 1.57, p < 0.001). CRBSI incidence density was statistically higher for femoral than for jugular (8.34 versus 2.99, p = 0.002) and subclavian (8.34 versus 0.97, p < 0.001) accesses, and higher for jugular than for subclavian access (2.99 versus 0.97, p = 0.005).
Our results suggest that the order for punction, to minimize the CVC-related infection risk, should be subclavian (first order), jugular (second order) and femoral vein (third order).
中心静脉置管在重症患者中常用,可能引发包括感染在内的不同并发症。尽管有许多关于中心静脉导管相关感染的研究,但很少有对其进行详细分析的。本研究的目的是根据不同穿刺部位分析中心静脉导管(CVC)相关局部感染(CRLI)和导管相关血流感染(CRBSI)的发生率。
这是一项前瞻性观察研究,在一家拥有650张床位的大学医院的一个有24张床位的内科外科重症监护病房进行。纳入了在3年期间(2000年5月1日至2003年4月30日)连续入住重症监护病房的所有患者。
该研究纳入了2018例患者。中心静脉导管的数量和置管天数分别为:总体,2595根和18999天;锁骨下,917根和8239天;颈内,1390根和8361天;股静脉,288根和2399天。股静脉穿刺部位的CRLI发病密度在统计学上高于颈内静脉(15.83对7.65,p<0.001)和锁骨下静脉(15.83对1.57,p<0.001),颈内静脉高于锁骨下静脉(7.65对1.57,p<0.001)。股静脉穿刺部位的CRBSI发病密度在统计学上高于颈内静脉(8.34对2.99,p = 0.002)和锁骨下静脉(8.34对0.97,p<0.001),颈内静脉高于锁骨下静脉(2.99对0.97,p = 0.005)。
我们的结果表明,为将中心静脉导管相关感染风险降至最低,穿刺顺序应为锁骨下静脉(一级)、颈内静脉(二级)和股静脉(三级)。